Risk Assessments
Risk assessments are reviewed by the Standing Advisory Committee on Transfusion Transmitted Infection (SACTTI) on a rolling basis or whenever significant changes are identified. The following risk assessments have been completed:
- Babesia - June 2023
- Borrelia burgdorferi (Lyme Disease) - June 2022
- Chikungunya Virus - March 2023
- Crimean-Congo Haemorrhagic Fever (CCHF) - September 2023
- Dengue Virus - September 2023
- Ebola - June 2021
- H5N1 Pandemic Influenza - June 2019
- Hepatitis A (HAV) - November 2022
- Hepatitis E (HEV) - June 2017
- Human Herpesvirus 8 (HHV-8) - September 2023
- Human Parvovirus PARV 4 (previously B19) - September 2023
- Lymphocytic Choriomeningitis Virus (LCMV) - November 2018
- Leishmania - June 2023
- Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - September 2019
- Mpox (formerly Monkeypox) - September 2023
- Seasonal Influenza A (Non Pandemic) - June 2019
- Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-1) - June 2019
- Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) - June 2023
- Simian Foamy Virus (SFV) - March 2020
- Tick-Borne Encephalitis Virus (TBEV) - March 2022
- Toxoplasmosis - June 2023
- Usutu Virus (USU) - June 2023
- Variant Creutzfeldt-Jakob Disease (vCJD) - March 2020
- Xenotropic Murine Leukaemia Related Virus (XMRV) - June 2019
- Yellow Fever - March 2023
- ZIka Virus - November 2022
Risk assessments are available on request. Please contact JPACOffice@nhsbt.nhs.uk for more information.